HONG KONG– A newly discovered human monoclonal antibody (MAb) that can neutralize several different types of influenza A virus may represent a new antiviral treatment and potentially lead to the development of new more potent vaccines, according to a Chinese study reported in the July 21, 2015, issue of Nature Communications.
HONG KONG – The discovery by Japanese researchers of a single nucleotide polymorphism (SNP) in a gene linked to increased susceptibility to adolescent idiopathic scoliosis (AIS), could lead to the identification of new therapeutic targets for this common and currently incurable condition.
HONG KONG– A newly discovered human monoclonal antibody (MAb) that can neutralize several different types of influenza A virus may represent a new antiviral treatment and potentially lead to the development of new more potent vaccines, according to a Chinese study reported in the July 21, 2015, issue of Nature Communications.
HONG KONG – The discovery by Japanese researchers of a single nucleotide polymorphism (SNP) in a gene linked to increased susceptibility to adolescent idiopathic scoliosis (AIS), could lead to the identification of new therapeutic targets for this common and currently incurable condition.
HONG KONG – An oral cholera vaccine has been shown to be safe and protective against severe disease in children and adults in urban Bangladesh where the disease is endemic, supporting its use in mass immunization programs, according to the first real-life trial of the new Shanchol vaccine.
HONG KONG — An oral cholera vaccine has been shown to be safe and protective against severe disease in children and adults in urban Bangladesh where the disease is endemic, supporting its use in mass immunization programs, according to the first real-life trial of the new Shanchol vaccine.
HONG KONG – The mechanism by which the thalidomide derivative lenalidomide treats a type of myelodysplastic syndrome (MDS) has been elucidated, reported in the July 1, 2015, edition of Nature, could aid the development of new therapies for leukemias and other malignancies.
HONG KONG – The mechanism by which the thalidomide derivative lenalidomide treats a type of myelodysplastic syndrome (MDS) has been elucidated, reported in the July 1, 2015, edition of Nature, could aid the development of new therapies for leukemias and other malignancies.
HONG KONG – Chinese researchers have discovered a novel nonasaccharide molecule – a nine-unit sugar chain – with potent anticoagulant activity that could avoid adverse effects, paving the way for the development of better treatments for thromboembolic diseases, they reported in the June 22, 2015, early online issue of Proceedings of the National Academy of Sciences.
HONG KONG – An extract of a mushroom used in traditional Chinese medicine (TCM) reduces obesity in mice by altering the composition of the gut microbiota, suggesting it may prove useful for treating obesity and associated disorders in humans, according to a Taiwan study reported in the June 23, 2015, edition of Nature Communications.
